tradingkey.logo

Aclarion Inc

ACON
7.500USD
-0.330-4.21%
Close 11/04, 16:00ETQuotes delayed by 15 min
4.37MMarket Cap
LossP/E TTM

Aclarion Inc

7.500
-0.330-4.21%

More Details of Aclarion Inc Company

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.

Aclarion Inc Info

Ticker SymbolACON
Company nameAclarion Inc
IPO dateApr 22, 2022
CEOMr. Brent Ness
Number of employees6
Security typeOrdinary Share
Fiscal year-endApr 22
Address8181 Arista Place
CityBROOMFIELD
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80021
Phone18332752266
Websitehttps://aclarion.com/
Ticker SymbolACON
IPO dateApr 22, 2022
CEOMr. Brent Ness

Company Executives of Aclarion Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.00
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
1.00
--
Mr. Gregory A. (Greg) Gould
Mr. Gregory A. (Greg) Gould
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Dr. Scott Breidbart, M.D.
Dr. Scott Breidbart, M.D.
Independent Director
Independent Director
--
--
Mr. David Neal
Mr. David Neal
Director
Director
--
--
Dr. Jeff Thramann, M.D.
Dr. Jeff Thramann, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.00
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
1.00
--
Mr. Gregory A. (Greg) Gould
Mr. Gregory A. (Greg) Gould
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--

Revenue Breakdown

No Data
No Data
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Aug 23
Updated: Sat, Aug 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.32%
UBS Financial Services, Inc.
0.30%
Tower Research Capital LLC
0.01%
Other
98.32%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.32%
UBS Financial Services, Inc.
0.30%
Tower Research Capital LLC
0.01%
Other
98.32%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.35%
Investment Advisor/Hedge Fund
0.32%
Hedge Fund
0.01%
Other
98.32%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
9
10.66K
1.68%
+7.30K
2025Q2
17
378.00
0.06%
-14.00
2025Q1
19
368.00
0.06%
+366.00
2024Q4
16
3.00
0.00%
-7.00
2024Q3
21
2.00
0.00%
-10.00
2024Q2
27
2.00
7.77%
-3.00
2024Q1
28
3.00
9.70%
--
2023Q4
35
1.00
14.29%
-1.00
2023Q3
34
1.00
25.00%
-1.00
2023Q2
33
1.00
25.00%
-1.00
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
1.71K
0.29%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
1.59K
0.27%
+610.00
+62.37%
Aug 31, 2025
UBS Financial Services, Inc.
1.73K
0.3%
+1.68K
+3225.00%
Jun 30, 2025
Tower Research Capital LLC
75.00
0.01%
+72.00
+2400.00%
Jun 30, 2025
Thramann (Jeffrey John)
10.00
0%
+10.00
--
May 09, 2025
BofA Global Research (US)
8.00
0%
+4.00
+100.00%
Jun 30, 2025
Clear Street LLC
3.00
0%
--
--
Jun 30, 2025
Ness (Brent)
3.00
0%
+3.00
--
May 09, 2025
Neal (David K)
2.00
0%
+2.00
--
May 09, 2025
Wesemann (William G)
1.00
0%
+1.00
--
May 09, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Date
Type
Ratio
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 02, 2024
Merger
16→1
Jan 02, 2024
Merger
16→1
View more
KeyAI